- Home
- GRABW vs CINGW Comparison
GRABW vs CINGW Comparison
Compare GRABW & CINGW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRABW
- CINGW
- Stock Information
- Founded
- GRABW N/A
- CINGW N/A
- Country
- GRABW Singapore
- CINGW United States
- Employees
- GRABW 10604
- CINGW 13
- Industry
- GRABW Business Services
- CINGW Biotechnology: Pharmaceutical Preparations
- Sector
- GRABW Consumer Discretionary
- CINGW Health Care
- Exchange
- GRABW Nasdaq
- CINGW Nasdaq
- Market Cap
- GRABW N/A
- CINGW N/A
- IPO Year
- GRABW N/A
- CINGW 2021
- Fundamental
- Price
- GRABW $0.20
- CINGW $0.07
- Analyst Decision
- GRABW
- CINGW
- Analyst Count
- GRABW 0
- CINGW 0
- Target Price
- GRABW N/A
- CINGW N/A
- AVG Volume (30 Days)
- GRABW N/A
- CINGW N/A
- Earning Date
- GRABW N/A
- CINGW N/A
- Dividend Yield
- GRABW N/A
- CINGW N/A
- EPS Growth
- GRABW N/A
- CINGW N/A
- EPS
- GRABW N/A
- CINGW N/A
- Revenue
- GRABW N/A
- CINGW N/A
- Revenue This Year
- GRABW N/A
- CINGW N/A
- Revenue Next Year
- GRABW N/A
- CINGW N/A
- P/E Ratio
- GRABW N/A
- CINGW N/A
- Revenue Growth
- GRABW N/A
- CINGW N/A
- 52 Week Low
- GRABW N/A
- CINGW N/A
- 52 Week High
- GRABW N/A
- CINGW N/A
- Technical
- Relative Strength Index (RSI)
- GRABW 48.01
- CINGW N/A
- Support Level
- GRABW $0.21
- CINGW N/A
- Resistance Level
- GRABW $0.27
- CINGW N/A
- Average True Range (ATR)
- GRABW 0.02
- CINGW 0.00
- MACD
- GRABW -0.00
- CINGW 0.00
- Stochastic Oscillator
- GRABW 14.16
- CINGW 0.00
About GRABW Grab Holdings Limited Warrant
Founded in 2012, Grab provides ride-sharing services, food and grocery delivery, and financial services (payments, consumer loans, and enterprise offerings) in eight Southeast-Asian countries through its mobile platform. The company partners with merchants and riders, connecting them with consumers while charging commission to both sides. Grab has a leading market share in and derives 89% of its revenue from its core businesses, ride-sharing and food delivery. Singapore and Malaysia contributed 58% of revenue as of end-2021. Grab's main competitors in Southeast Asia are Foodpanda and Gojek, the ride-sharing arm of GoTo. Its financial services business is still in its nascent stage and provides minimal revenue currently. The company now also generates advertising revenue.
About CINGW Cingulate Inc.
Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic areas to use PTR technology to develop future product candidates.